Profile
TKNO ZTS TAK HLN TEVA NBIX
Company Name Alpha Teknova, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $73.07M $79.42B $41.48B $38.86B $18.26B $14.32B
Employees 0.21K 14.10K 49.10K 25.41K 35.00K 1.45K
CEO Mr. Stephen Gunstream Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Dr. Kevin C. Gorman Ph.D.
Ratings
TKNO ZTS TAK HLN TEVA NBIX
Quant Rating Score 2 5 3 4 3 5
Quant Rating Sell Strong Buy Neutral Buy Neutral Strong Buy
Trading
TKNO ZTS TAK HLN TEVA NBIX
Last Close $1.79 $174.06 $13.22 $8.51 $16.29 $142.29
High 52 $3.98 $200.09 $16.42 $8.95 $17.09 $143.19
Low 52 $1.66 $145.54 $13.03 $7.78 $7.2 $89.53
Price vs. 52 Week High -55.03 % -13.01 % -19.49 % -4.92 % -4.68 % -0.63 %
Price vs. 52 Week Low 7.83 % 19.6 % 1.46 % 9.38 % 126.25 % 58.93 %
Total Return
TKNO ZTS TAK HLN TEVA NBIX
1 Month Return -10.95 % 13.68 % 0.46 % 4.67 % 27.46 % 7.36 %
3 Month Return -43.35 % -7.61 % -9.58 % 3.53 % 25.12 % 7.54 %
6 Month Return -12.68 % -0.42 % -5.23 % 3.15 % 80 % 30.61 %
9 Month Return -31.42 % -4.14 % -12.16 % 3.4 % 70.4 % 33.03 %
YTD Return -52.01 % -11.81 % -7.36 % 3.4 % 56.03 % 7.99 %
1 Year Return -13.94 % -3.15 % -17.68 % 0.41 % 97.22 % 49.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TKNO ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 0.93 % 4.25 % 2.27 % - -
Dividend Paid and Capex Coverage Ration (TTM) -4.74 % 1.76 % 0.92 % - 3.3 % 20.82 %
Dividend Per Share (TTM) - 1.61 % 0.56 % 0.15 % - -
Payout Ratio (TTM) - 29.95 % 199.34 % - - -
Growth
TKNO ZTS TAK HLN TEVA NBIX
Asset Growth -15.55 % -4.28 % 5.92 % -2.18 % -1.2 % 37.27 %
Gross Profit Growth -47.65 % 3.7 % 13.05 % 5.85 % 9.64 % 26.06 %
Revenue Growth -11.43 % 5.74 % 12.85 % 4.09 % 6.16 % 26.76 %
Revenue 3 Year -3.81 % 31.98 % 22.8 % 13.9 % -6.92 % 71.93 %
Revenue 5 Year 49.81 % 53.64 % 128.91 % 32.87 % -23.33 % 308.36 %
Revenue 10 Year 49.81 % 103.1 % 163.14 % 32.87 % -40.82 % 44100.16 %
EBIT Growth -5.69 % 6.27 % 6.44 % 37.26 % -84.52 % 0.76 %
Net Income Growth 22.52 % 10.88 % 37.8 % -1.04 % 76.24 % 61.62 %
Net Income 3 Yeari Growth Per Share -945.44 % 47.55 % 619.06 % -8.67 % 86.29 % -41.58 %
Net Income 5 Yeari Growth Per Share -2212.83 % 71.94 % 70.7 % 59.66 % 76.28 % 1054.95 %
Net Income 10 Yeari Growth Per Share -2212.83 % 404.24 % 145.77 % 59.66 % -133.42 % 470.4 %
Operating Income Growth -5.69 % 6.27 % 6.44 % 37.26 % -84.52 % 0.76 %
Operating Cash Flow Growth (CFG) 31.16 % 23.06 % -13 % -16.48 % -13.96 % 14.88 %
Operating 3 Year CFG -717.87 % 14.12 % 46.41 % 22.08 % 10.09 % 62.6 %
Operating 5 Year CFG -812.6 % 37.69 % 160.24 % 118.54 % -48.98 % 275.6 %
Operating 10 Year CFG -812.6 % 274.61 % 223.1 % 118.54 % -67.94 % 1000.37 %
EPS Growth 31.36 % 12.64 % 38.84 % - 76.42 % 59.01 %
EPS Diluted Growth 31.36 % 12.92 % 38.44 % - 76.42 % 58.33 %
Book Value Per Share -20.44 % 15.34 % 12.65 % 1.38 % -5.72 % 28.15 %
Share Holder 3 Year Equity Growth Per Share 340.66 % 36.7 % 34.99 % -36.6 % -26.74 % 88.86 %
Share Holder 5 Year Equity Growth Per Share 472.31 % 139.55 % 220.13 % -39.41 % -53.44 % 353.33 %
Share Holder 10 Year Equity Growth Per Share 472.31 % 476.36 % 199.32 % -39.41 % -74.76 % 1167.34 %
Dividend Per Share Growth - 15.15 % -0.76 % -85.58 % - -
Dividend 3 Year Growth Per Share - 87.76 % -0.78 % -83.69 % - -
Dividend 5 Year Growth Per Share -23.41 % - 98.17 % -66.42 % - -
Dividend 10 Year Growth Per Share -23.41 % 665.58 % 100.04 % -66.42 % -100 % -
Debt Growth -28.01 % -15.91 % 0.85 % -9.43 % -6.53 % 62.95 %
Free Cash Flow Growth 51.76 % 22.25 % -63.35 % -20.06 % -19.19 % 11.99 %
Updated On 31 Dec 2023 31 Dec 2023 31 Mar 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
TKNO ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 25.8 % 69.2 % 62.16 % 60.04 % 48.99 % 97.78 %
Return on Assets TTM -29.85 % 16.66 % 0.95 % - -1.15 % 10.65 %
Return on Equity TTM -40.15 % 48.41 % 2.06 % 6.53 % -6.86 % 17.45 %
Return on Capital Employed TTM -27.36 % 25.86 % 1.76 % - 3.75 % 17.05 %
Net Income Per EBT TTM 99.14 % 80.07 % 293.72 % 64.62 % 59.18 % 78.68 %
EBT Per Ebit TTM 116.83 % 92.82 % 21.83 % 82.52 % -76.63 % 99.89 %
EBIT Per Revenue TTM -84.48 % 36.83 % 5.27 % 18.08 % 6.79 % 23.73 %
Cash Flow To Debt Ratio TTM -117.29 % 36.43 % 14.66 % - 8.57 % 118.01 %
Receivables Turnover TTM 8.08 6.75 6.11 - 4.63 4.4
Payables Turnover TTM 17.72 6.64 2.95 - 3.35 0.5
Inventory Turnover TTM 2.44 1.01 1.33 - 2.07 1.18
Fixed Asset Turnover TTM 55.58 % 251.27 % 214.28 % - 267.75 % 572.67 %
Asset Turnover TTM 30.5 % 60.87 % 28.22 % - 37.45 % 57.08 %
Operating Cash Flow Per Share TTM -0.43 5.24 452.81 - 1.5 6.47
Free Cash Flow Per Share TTM -0.53 3.82 146.32 - 1.04 6.16
Cash Per Share TTM 52.93 % 431.22 % 29187.13 % 22.71 % 266.34 % 1213.03 %
Operating Cash Flow Sales Ratio TTM -48.06 % 27.47 % 16.66 % - 10.51 % 32.56 %
Free Cash Flow Operating Cash Flow Ratio TTM 121.08 % 72.95 % 32.31 % - 69.66 % 95.2 %
Cash Flow Coverage Ratios TTM -117.29 % 36.43 % 14.66 % - 8.57 % 118.01 %
Price To Free Cash Flows Ratio TTM -3.41 45.38 28.13 - 15.57 23.31
Price To Operating Cash Flows Ratio TTM -4.12 33.23 4.54 - 10.86 22
Price Cash Flow Ratio TTM -4.12 33.23 4.54 - 10.86 22
Income Statement (TTM)
TKNO ZTS TAK HLN TEVA NBIX
Revenue $0.04B $8.54B $4263.76B $11.3B $15.85B $1.89B
Gross Profit $0.01B $5.83B $2184.97B $6.96B $7.65B $1.85B
Gross Profit Ratio 24.94% 68.28% 51.25% 61.6% 48.25% 97.9%
EBITDA $-0.02B $3.56B $1129.23B $2.81B $4.27B $0.42B
Net Income $-0.04B $2.34B $144.07B $1.05B $-0.56B $0.25B
EPS Diluted -1.16 5.07 91.16 0.11 -0.5 2.47
Balance Sheet (MRQ)
TKNO ZTS TAK HLN TEVA NBIX
Long Term Debt $0.01B $6.56B $4476.5B $8.8B $18.48B $0.26B
Total Liabilities $0.04B $9.3B $7834.79B $17.33B $35.35B $1.02B
Total Equity $0.09B $4.99B $7274.01B $16.73B $8.13B $2.23B
Total Investments $0B $0.02B $430.61B $0.07B $0.01B $0.94B
Total Debt $0.03B $6.8B $4843.75B $9.46B $20.15B $0.43B
Total Assets $0.13B $14.29B $15108.79B $34.06B $43.48B $3.25B
Cash Flow Statement (TTM)
TKNO ZTS TAK HLN TEVA NBIX
Net Income $-0.04B $2.34B $144.07B $1.05B $-0.62B $0.25B
Inventory $0B $-0.36B $-115.74B $-0.13B $-0.15B $0.01B
Dividends Paid $0B $-0.69B $-287.19B $-0.39B $0B $0B
Operating Cash Flow $-0.02B $2.35B $640.32B $1.72B $1.37B $0.39B
Capital Expenditure $-0.01B $-0.73B $-480.73B $-0.34B $-0.53B $-0.03B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 7.38
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 0.3777
AKAN Akanda Corp. 0.1726
ALIM Alimera Sciences, Inc. 3.2
ALVO Alvotech 13.5
ALVOW Alvotech 3.1
AMPH Amphastar Pharmaceuticals, Inc. 43.48
AMRX Amneal Pharmaceuticals, Inc. 6.82
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 61.43
AQST Aquestive Therapeutics, Inc. 3.11
ASRT Assertio Holdings, Inc. 1.07
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 15.49
AYTU Aytu BioPharma, Inc. 2.94
ETFs With Exposure to TKNO
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0011 208.08
VTI Vanguard Total Stock Market Index Fund 0 262.3
IBB iShares Biotechnology ETF 0 136.69
IWN iShares Russell 2000 Value ETF 0.00226 158.71
VHT Vanguard Health Care Index Fund 0 267.11
BIB ProShares Ultra Nasdaq Biotechnology 0 57.05
VXF Vanguard Extended Market Index Fund 0 173.42
HDG ProShares Hedge Replication ETF 0.00012199 49.615
UWM ProShares Ultra Russell2000 0.000270715 39.45
IWC iShares Micro-Cap ETF 0.00259 119.09
URTY ProShares UltraPro Russell2000 0.000198162 47.46
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 90.91
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 90.89
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.83
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.83
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.82
RYLD Global X Russell 2000 Covered Call ETF 0 16.49
IBBQ Invesco Nasdaq Biotechnology ETF 0.01 22.2071
DFAT Dimensional U.S. Targeted Value ETF 0.00010196 54.33
DFAC Dimensional U.S. Core Equity 2 ETF 0.000098 32.05
VTSAX Vanguard Total Stock Market Index Fund 0 127.64
MMSC First Trust Multi-Manager Small Cap Opportunities ETF 0.01 19.5479
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 6.4025
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.58
VITSX Vanguard Total Stock Market Index Fund 0 127.66
DFSU Dimensional US Sustainability Core 1 ETF 0 34.37
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000486704 89.84
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.58
SWSSX Schwab Small-Cap Index Fund-Select Shares 0 33.78
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 133.63
DCOR Dimensional ETF Trust 0.00198953 58.89
VEMPX Vanguard Extended Market Index InstlPlus 0 324.71
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 239.45
Unlock